CheKine™ Micro ALP Activity Assay Kit: Illuminating Bone, Liver, and Cancer Research

ALP: The Double-Edged Sword of Clinical Biomarkers

Alkaline phosphatase (AKP/ALP) is a critical biomarker for bone health, liver function, and certain cancers[reference:58]. But measuring its activity reliably in tiny samples has long been a challenge. Traditional ALP assays demand milliliters of serum or tissue homogenate, suffer from poor sensitivity in low-activity samples, and drown in matrix interference from bilirubin, heme, or lipids[reference:59].

Abbkine's CheKine™ Micro Tissue and Blood Alkaline Phosphatase (AKP/ALP) Activity Assay Kit (KTB1700) revolutionizes microsample ALP detection, making it as easy as it is accurate[reference:60].

Bone Health & Metabolic Bone Disease

ALP is the primary biomarker for osteoblast activity and bone formation. The kit enables:

• Rickets and osteomalacia research — detecting ALP dips in vitamin D-deficient patients[reference:61]
• Osteoporosis studies — tracking bone turnover in aging populations
• Paget's disease — monitoring elevated ALP in bone remodeling disorders
• Pediatric bone health — working with limited pediatric samples[reference:62]

Hepatobiliary & Liver Disease Research

ALP elevation is a hallmark of cholestatic liver disease. The kit supports:

• Cholestasis research — distinguishing intrahepatic from extrahepatic causes[reference:63]
• Drug-induced liver injury — monitoring ALP as a hepatotoxicity marker
• Primary biliary cholangitis — tracking disease progression
• Liver fibrosis and cirrhosis — assessing biliary involvement

Oncology & Cancer Research

ALP is elevated in various cancers, particularly:

• Metastatic prostate cancer — detecting ALP spikes[reference:64]
• Bone metastases — monitoring tumor burden in bone
• Hepatocellular carcinoma — tracking ALP in liver tumors

How It Works: The Modified pNPP Method

The kit uses a modified p-nitrophenyl phosphate (pNPP) method optimized for 10–20 µL samples—5x less than standard kits—by amplifying the yellow p-nitrophenol signal (λmax = 405 nm) via a proprietary buffer that stabilizes the reaction[reference:65]. The lower limit of detection is 0.1 U/L (vs. 0.5 U/L for competitors)[reference:66].

Sample Compatibility & Key Features

• Sample types: Tissue lysate supernatants, plasma, serum, urine, purified enzyme samples[reference:67]
• Matrix correction protocol: Sample-specific blanks cut interference by 85%[reference:68]
• Micro blood ALP detection: Reliable data from a single finger prick[reference:69]
• Pediatric applications: Detects ALP dips in vitamin D-deficient infants[reference:70]

Clinical Impact

A 2024 survey of 180 clinical labs found 65% struggle with low-volume ALP quantification (≤20 µL samples), citing insufficient sensitivity, large sample needs, and interference galore[reference:71]. KTB1700 solves all three problems in one kit.

📊 Your Research Area?
Bone Metabolism | Hepatology | Oncology | Pediatrics | Clinical Diagnostics

👉 Quantify ALP activity with confidence. View Product